INTERNATIONAL PATENT: CARMOT THERAPEUTICS INC., GENENTECH, INC. FILES APPLICATION FOR "COMBINATION THERAPY OF PEPTIDE TYROSINE-TYROSINE (PYY) ANALOGUES AND GLP-1R AGONISTS"

GENEVA, April 8 -- CARMOT THERAPEUTICS INC. (1 DNA WaySouth San Francisco, California 94080-4990), GENENTECH, INC. (1 DNA Way, MS-49,South San Francisco, California 94080-4990) filed a patent application (PCT/US2025/048291) for "COMBINATION THERAPY OF PEPTIDE TYROSINE-TYROSINE (PYY) ANALOGUES AND GLP-1R AGONISTS" on Sep 26, 2025. With publication no. WO/2026/073030, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHAKRAVARTHY, Manu (c/o Carmot Therapeutics Inc.1 DNA WaySouth San Francisco, California 94080-4990), CHEN, Zh...